158 related articles for article (PubMed ID: 38150061)
21. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
[TBL] [Abstract][Full Text] [Related]
22. Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.
Avery RA; Mansoor A; Idrees R; Biggs E; Alsharid MA; Packer RJ; Linguraru MG
Neurology; 2016 Jun; 86(24):2264-70. PubMed ID: 27170570
[TBL] [Abstract][Full Text] [Related]
23. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S
Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
[TBL] [Abstract][Full Text] [Related]
24. Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.
Henning AM; Handrup MM; Kjeldsen SM; Larsen DA; Ejerskov C
Orphanet J Rare Dis; 2021 Nov; 16(1):489. PubMed ID: 34809690
[TBL] [Abstract][Full Text] [Related]
25. Measurements of Retinal Nerve Fiber Thickness and Ganglion Cell Complex in Neurofibromatosis Type 1, with and Without Optic Pathway Gliomas: A Case Series.
Sahinoglu-Keskek N; Altan-Yaycioglu R; Canan H; Coban-Karatas M; Erbay A; Yazıcı N; Alkan O
Curr Eye Res; 2018 Mar; 43(3):424-427. PubMed ID: 29185816
[TBL] [Abstract][Full Text] [Related]
26. Isolated optic nerve gliomas: a multicenter historical cohort study.
Shofty B; Ben-Sira L; Kesler A; Jallo G; Groves ML; Iyer RR; Lassaletta A; Tabori U; Bouffet E; Thomale UW; Hernáiz Driever P; Constantini S;
J Neurosurg Pediatr; 2017 Dec; 20(6):549-555. PubMed ID: 28984541
[TBL] [Abstract][Full Text] [Related]
27. Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab.
Avery RA; Hwang EI; Jakacki RI; Packer RJ
JAMA Ophthalmol; 2014 Jan; 132(1):111-4. PubMed ID: 24232489
[TBL] [Abstract][Full Text] [Related]
28. Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1.
Shaikh F; Johnston D; Michaud J; Hurteau J; Vassilyadi M; Keene D
Pediatr Blood Cancer; 2011 Oct; 57(4):688-6690. PubMed ID: 21465640
[TBL] [Abstract][Full Text] [Related]
29. NF1-like optic pathway gliomas in children: clinical and molecular characterization of this specific presentation.
Lobón-Iglesias MJ; Laurendeau I; Guerrini-Rousseau L; Tauziède-Espariat A; Briand-Suleau A; Varlet P; Vidaud D; Vidaud M; Brugieres L; Grill J; Pasmant E
Neurooncol Adv; 2020 Jul; 2(Suppl 1):i98-i106. PubMed ID: 32642735
[TBL] [Abstract][Full Text] [Related]
30. Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary?
Maloney E; Stanescu AL; Perez FA; Iyer RS; Otto RK; Leary S; Steuten L; Phipps AI; Shaw DWW
Pediatr Radiol; 2018 Sep; 48(10):1472-1484. PubMed ID: 29789890
[TBL] [Abstract][Full Text] [Related]
31. Visual field outcomes in children treated for neurofibromatosis type 1-associated optic pathway gliomas: a multicenter retrospective study.
Heidary G; Fisher MJ; Liu GT; Ferner RE; Gutmann DH; Listernick RH; Kapur K; Loguidice M; Ardern-Holmes SL; Avery RA; Hammond C; Hoffman RO; Hummel TR; Kuo A; Reginald A; Ullrich NJ
J AAPOS; 2020 Dec; 24(6):349.e1-349.e5. PubMed ID: 33221469
[TBL] [Abstract][Full Text] [Related]
32. Natural history and clinical management of optic pathway glioma.
Astrup J
Br J Neurosurg; 2003 Aug; 17(4):327-35. PubMed ID: 14579898
[TBL] [Abstract][Full Text] [Related]
33. Automatic segmentation and components classification of optic pathway gliomas in MRI.
Weizman L; Ben-Sira L; Joskowicz L; Precel R; Constantini S; Ben-Bashat D
Med Image Comput Comput Assist Interv; 2010; 13(Pt 1):103-10. PubMed ID: 20879220
[TBL] [Abstract][Full Text] [Related]
34. Regression and pseudoprogression of pediatric optic pathway glioma in patients treated with proton beam therapy.
Youn SH; Kim H; Lee SH; Kim JY
Pediatr Blood Cancer; 2022 Mar; 69(3):e29434. PubMed ID: 34766717
[TBL] [Abstract][Full Text] [Related]
35. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
[TBL] [Abstract][Full Text] [Related]
36. Diffusion-weighted and dynamic contrast-enhanced imaging as markers of clinical behavior in children with optic pathway glioma.
Jost SC; Ackerman JW; Garbow JR; Manwaring LP; Gutmann DH; McKinstry RC
Pediatr Radiol; 2008 Dec; 38(12):1293-9. PubMed ID: 18846370
[TBL] [Abstract][Full Text] [Related]
37. Optic pathway-hypothalamic glioma hemorrhage: a series of 9 patients and review of the literature.
van Baarsen K; Roth J; Serova N; Packer RJ; Shofty B; Thomale UW; Cinalli G; Toledano H; Michowiz S; Constantini S
J Neurosurg; 2018 Dec; 129(6):1407-1415. PubMed ID: 29424646
[TBL] [Abstract][Full Text] [Related]
38. An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.
Chen Y; Yu J; Ge S; Jia R; Song X; Wang Y; Fan X
Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):8. PubMed ID: 38837168
[TBL] [Abstract][Full Text] [Related]
39. MRI internal segmentation of optic pathway gliomas: clinical implementation of a novel algorithm.
Shofty B; Weizman L; Joskowicz L; Constantini S; Kesler A; Ben-Bashat D; Yalon M; Dvir R; Freedman S; Roth J; Ben-Sira L
Childs Nerv Syst; 2011 Aug; 27(8):1265-72. PubMed ID: 21452004
[TBL] [Abstract][Full Text] [Related]
40. Treatment and Outcome in 65 Children with Optic Pathway Gliomas.
El Beltagy MA; Reda M; Enayet A; Zaghloul MS; Awad M; Zekri W; Taha H; El-Khateeb N
World Neurosurg; 2016 May; 89():525-34. PubMed ID: 26898488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]